Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 28 Jul 2020 |
2 | Reply to Exam Report (MIS-R) | 24 Sep 2020 |
3 | Journal Copy | 23 Oct 2020 |
4 | TM-O(NOTICE OF OPPOSITION) | 16 Feb 2021 |
5 | Annexure -1 under rule 46 | 03 Sep 2021 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 03 Sep 2021 |
6 | Annexure -1 under rule 46 | 03 Sep 2021 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 03 Sep 2021 |
1 | EXAMINATION REPORT | 10324623 | 27 Aug 2020 | |
2 | Opposition Notice | 11123874 | 5117833 | 17 Feb 2021 |
3 | Opposition Counter Statement | 11393069 | 5180450 | 16 Apr 2021 |
The application for Etostri was made on 28 July 2020.
The trademark applicant for Etostri is STRIDES PHARMA SCIENCE.
Etostri is applied in class(es) 5.
Application for Etostri is on Opposed stage.
Application Id allotted to Etostri is 4585839.
Trademark agent or attorney for the application is Altacit Global.
Etostri filed with the Intellectual property office as a WORD.